Public Health · Internal Medicine · 7 h ago
WHO and EIB Global sign €10 million grant agreement for Lebanon’s public health
WHO and EIB Global signed a €10 million grant agreement to strengthen public health in Lebanon. The initiative aims to re-establish the Central Public Health Laboratory and provide medication and healthcare support to more than 50,000 people with chronic diseases.
- €10 million grant will support public health across Lebanon.
- The initiative will re-establish Lebanon’s Central Public Health Laboratory.
- Medication and healthcare support will target over 50,000 chronic disease patients.
WHO and EIB Global signed an agreement on 6 March 2025 for a €10 million grant to strengthen public health across Lebanon. WHO Director-General Dr Tedros Adhanom Ghebreyesus and EIB Global Vice-President Thomas Östros signed the agreement at the EIB Group Forum in Luxembourg. The initiative will re-establish Lebanon’s Central Public Health Laboratory and prioritize medication provision and healthcare support for more than 50,000 people with chronic diseases, including diabetes, cardiovascular disease and cancer. The announcement describes planned support rather than completed activities or measured health outcomes; it does not provide an implementation timeline or details of the medications and services to be supplied.
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
WHO – News: Strengthening public health across Lebanon with EIB Global ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.